Table 3. Long-term COVID-19-related diseases in opium users and non-opium users based on the disease severity.
Variables | Opium non-user (n = 225) | Opium user (n = 56) | p-value | |
---|---|---|---|---|
Non severe COVID-19 | ||||
Heart disease (positive) | 6 (6) | 8 (23) | 0.005* | |
Lung disease (positive) | 1 (1) | 10 (29) | < 0.001* | |
Kidney disease (positive) | 1 (1) | 1 (3) | 0.444* | |
Hospitalization days | 5 [4, 5.6] | 5.5 [3, 6.25] | 0.978† | |
Overall mortality | - | - | - | |
Severe COVID-19 | ||||
Heart disease (positive) | 7 (6) | 0 | 0.594* | |
Lung disease (positive) | 0 | 4 (19) | < 0.001* | |
Kidney disease (positive) | 2 (1.7) | 0 | > 0.999* | |
Hospitalization days | 5 [4, 7] | 6 [5, 7] | 0.114† | |
Overall mortality | 0 | 1 (5) | 0.148* |
Data are presented as number (%) or median (interquartile range).
COVID-19, coronavirus disease 2019.
*χ2 and †Mann Whitney test Q2 [Q1–Q3] were used for statistical comparisons.